RxforUSA

Product # : 1197690 Class : MCKSN Distributor : RELIANCE INC Category : Test Kits Availability : Stocked

$0.00

Product Notices : This product may be non-returnable and/or require additional restocking fee.

$913.01

- +

Add To Wishlist Add To Cart

Buy Now

Product No. #	1197690
Manufacturer #	L016000109048
Brand	LumiraDx™
Manufacturer	LumiraDx Inc
Application	Respiratory Test Kit
For Use With	For use with the LumiraDx Platform
Number of Tests	48 Tests
Sample Type	Nasal Swab Sample
Shipping Width	8.5
Shipping Height	4
Shipping Depth	9.5
Dimension UOM	IC
Shipping Weight	1.1
Weight UOM	LB
For_Use_With	For use with the LumiraDx Platform
QTY_Per_Sell	1
Simply_Medical_Category	Test Kits
Reading_Type	Machine Read
Supply_Manager_Category	Test Kits
Supply_Manager_Hierarchy	Clinical Laboratory>Test Kits>Respiratory Test Kit
Legend_Code	No
Stock_Status	Stocked
Velocity	Medium Selling
Ready to Sell	Ready to sell

Results in 12 minutes
Results are for the identification of SARS-CoV-2 nucleocapsid protein antigen; antigen is generally detectable in nasal swab specimens during the acute phase of infection.
The LumiraDx SARS-CoV-2 Ag test does not differentiate between SARS-CoV and SARS-CoV-2.
Rapid microfluidic immunofluorescence assay test method
LumiraDx SARS-CoV-2 Ag Test is for use under an Emergency Use Authorization only.
Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C 263a, that meet the requirements to perform moderate, high or waived complexity tests.
Test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.
LumiraDx SARS-CoV-2 Ag Test is intended for use by trained clinical laboratory personnel and individuals trained in point of care settings, and proficient in performing tests using the LumiraDx Instrument.
48 tests